---
title: "SANERGY GROUP granted 100 million stock options"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/273992266.md"
description: "On January 28, 2026, SANERGY GROUP granted 100 million stock options to 24 eligible participants, with an exercise price of HKD 0.106 per share. 40.3 million stock options were granted to directors, 51.7 million to other employees, and 8 million to related entity participants"
datetime: "2026-01-28T12:55:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273992266.md)
  - [en](https://longbridge.com/en/news/273992266.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273992266.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/273992266.md) | [English](https://longbridge.com/en/news/273992266.md)


# SANERGY GROUP granted 100 million stock options

According to the Zhitong Finance APP, SANERGY GROUP (02459) announced that on January 28, 2026, the company granted a total of 100 million stock options to 24 eligible participants, with an exercise price of HKD 0.106 per share. Among them, 40.3 million stock options were granted to directors, 51.7 million stock options were granted to other employees of the group, and the remaining 8 million stock options were granted to related entity participants

### 相關股票

- [SANERGY GROUP (02459.HK)](https://longbridge.com/zh-HK/quote/02459.HK.md)

## 相關資訊與研究

- [22:00 ETHEARTS ON FIRE CELEBRATES 30 YEARS OF BRILLIANCE WITH NEW GLOBAL CAMPAIGN WHAT'S YOUR SIGNATURE?](https://longbridge.com/zh-HK/news/281450272.md)
- [CICC Remains a Buy on Zhongsheng Group Holdings Ltd. (0881)](https://longbridge.com/zh-HK/news/280899320.md)
- [CSPC Pharmaceutical, Alphamab Oncology's Breast Cancer Drug Study Meets Primary Endpoint](https://longbridge.com/zh-HK/news/281325910.md)
- [China's detentions of Panama-flagged vessels raise concerns, Rubio says](https://longbridge.com/zh-HK/news/281541796.md)
- [Tesla Sold Over 358K Vehicles Globally In Q1, BYD Nearly Matches Total For Just Exports](https://longbridge.com/zh-HK/news/281564232.md)